Resveratrol and Longevity: The Polyphenol Behind the French Paradox

Resveratrol is a stilbene polyphenol produced by plants in response to stress, injury, or fungal infection. It is found in the skin of red grapes, red wine, blueberries, raspberries, mulberries, and Japanese knotweed (the most concentrated natural source). It gained scientific attention in 1997 when Jang et al. published a landmark paper in Science showing that resveratrol inhibited skin cancer development in mice at multiple stages of carcinogenesis. In 2003, David Sinclair's laboratory at Harvard showed that resveratrol activated SIRT1 — a sirtuin enzyme associated with caloric restriction and longevity — igniting enormous scientific and commercial interest. Resveratrol became one of the most studied natural compounds of the 2000s.

Mechanisms: SIRT1 Activation and Beyond. Resveratrol's proposed mechanisms of action include: (1) SIRT1 activation — SIRT1 is a NAD+-dependent deacetylase that regulates metabolism, inflammation, DNA repair, and stress resistance. Resveratrol was initially reported to be a direct SIRT1 activator, though this has been contested — some researchers argue the activation is indirect, mediated through AMPK. (2) AMPK activation — resveratrol activates AMP-activated protein kinase (AMPK), the cellular energy sensor that mimics the effects of caloric restriction. (3) Anti-inflammatory effects — resveratrol inhibits NF-kB and COX-2, reducing inflammatory cytokine production. (4) Anti-cancer mechanisms — resveratrol induces apoptosis in cancer cells, inhibits angiogenesis, and modulates oestrogen receptor signalling (relevant to hormone-sensitive cancers). (5) Cardioprotective effects — resveratrol improves endothelial function, reduces LDL oxidation, and inhibits platelet aggregation.

Animal Studies: Impressive but Not Fully Translated. Animal studies with resveratrol have produced remarkable results: Baur et al. (Nature, 2006) found that high-dose resveratrol extended lifespan and improved metabolic health in obese mice fed a high-fat diet. Lagouge et al. (Cell, 2006) found that resveratrol improved mitochondrial function and protected against diet-induced obesity in mice. However, the doses used in these studies — when scaled to human body weight — are far higher than what is achievable through diet or standard supplementation. A 70kg human would need to drink approximately 1,000 bottles of red wine per day to match the resveratrol doses used in the mouse studies.

Human Clinical Trials: A More Mixed Picture. The human evidence for resveratrol is less dramatic than the animal data: A 2011 RCT by Timmers et al. (Cell Metabolism) found that 150mg/day of resveratrol for 30 days improved metabolic health markers in obese men, mimicking some effects of caloric restriction. A 2014 RCT by Bhatt et al. found that resveratrol improved insulin sensitivity in patients with type 2 diabetes. However, a 2014 study by Gliemann et al. found that high-dose resveratrol (250mg/day) actually blunted the cardiovascular benefits of exercise training in older men — a concerning finding that suggests resveratrol may interfere with exercise adaptation at high doses. The cancer prevention evidence in humans is largely epidemiological (red wine consumption and cancer risk) rather than from clinical trials.